Injectable protocatechuic acid based composite hydrogel with hemostatic and antioxidant properties for skin regeneration
[Display omitted] •An injectable hydrogel with both hemostatic and antioxidant properties is developed.•The preparation method of multifunctional hydrogel is gentle and simple.•The hydrogel can significantly accelerate the healing of full-thickness skin wounds. Acute skin injuries require timely and...
Gespeichert in:
Veröffentlicht in: | Materials & design 2022-10, Vol.222, p.111109, Article 111109 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•An injectable hydrogel with both hemostatic and antioxidant properties is developed.•The preparation method of multifunctional hydrogel is gentle and simple.•The hydrogel can significantly accelerate the healing of full-thickness skin wounds.
Acute skin injuries require timely and effective treatment. Injectable self-healing hydrogels are a very promising approach, but they face many challenges because of the complex microenvironments of skin wound. Although hydrogels have been extensively studied for multifunction, injectable self-healing hydrogels with both hemostatic and antioxidant properties are rare. In this paper, gelatin grafted protocatechuic acid (GT-PCA) and oxidized-dextran (Odex) were used to engineer GT-PCA/Odex composite hydrogels via Schiff base reaction. The in vitro experimental results show that the hydrogels not only are injectable, self-healing, hemostatic, antioxidant, but also have good degradability, adhesion and biocompatibility. Further, the hydrogels can promote wound healing in full-thickness mouse skin defect models by reducing inflammation and increasing angiogenesis, collagen deposition and granulation tissue formation. Notably, the preparation method of GT-PCA/Odex hydrogels is gentle and simple, the hydrogel system has bright prospects in the treatment of acute skin injury and is expected to be applied in clinical trials. |
---|---|
ISSN: | 0264-1275 1873-4197 |
DOI: | 10.1016/j.matdes.2022.111109 |